Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:NASDAQ:ALLO) Q1 2022 Earnings Conference Call May 04, 2022 05:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang...

Related Keywords

California ,United States ,American ,Susan Lundeen ,Kalpit Patel ,Cory Kasimov ,Raymond James ,Christine Cassiano ,Rafael Amado ,John Newman ,Eric Schmidt ,Dane Leone ,Tyler Van Buren ,Anand Sankar ,Raju Prasad ,Salveen Richter ,David Chang ,William Blair ,Company Participants ,American Association For Cancer Research Annual Meeting ,Allogene Therapeutics Inc ,Jp Morgan ,Communications Officer ,Goldman Sachs ,Nasdaq ,Allogene Therapeutics ,Conference Call May ,Chief Executive ,Chief Medical ,Van Buren ,Allogene Therapeutics First Quarter ,Chief Communications ,Chief Executive Officer ,Executive Vice President ,Chief Medical Officer ,Chief Financial ,Cell Forge ,Chief People Officer ,Springworks Therapeutics ,Cancer Research Annual Meeting ,